NCT04512105View on ClinicalTrials.gov

Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

December 2, 2020

Primary Completion Date

July 20, 2024

Study Completion Date

February 5, 2025

Conditions
Acute Myeloid LeukemiaChronic Lymphocytic LeukemiaAML, AdultCLLCLL, RelapsedCLL, Refractory
Interventions
DRUG

Pitavastatin

Given PO

DRUG

Venetoclax

Given PO

Trial Locations (1)

92868

Chao Family Comprehensive Cancer Center, University of California, Irvine, Orange

All Listed Sponsors
collaborator

United States Department of Defense

FED

lead

University of California, Irvine

OTHER

NCT04512105 - Pitavastatin in Combination With Venetoclax for Chronic Lymphocytic Leukemia or Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter